Virtual Screening for UDP-Galactopyranose Mutase Ligands Identifies a New Class of Antimycobacterial AgentsRecognition of microbial glycans by human intelectin-1High-throughput discovery of synthetic surfaces that support proliferation of pluripotent cells.Peptide ligands that use a novel binding site to target both TGF-β receptors.Inter-receptor communication through arrays of bacterial chemoreceptors.A unique catalytic mechanism for UDP-galactopyranose mutase.Rhamnose glycoconjugates for the recruitment of endogenous anti-carbohydrate antibodies to tumor cells.Structures of Xenopus Embryonic Epidermal Lectin Reveal a Conserved Mechanism of Microbial Glycan Recognition.Glycomimetic building blocks: a divergent synthesis of epimers of shikimic acid.Monitoring processivity and length control of a carbohydrate polymerase.Quinoxalinone Inhibitors of the Lectin DC-SIGN.Synthetic multivalent ligands as probes of signal transductionNon-carbohydrate inhibitors of the lectin DC-SIGN.UDP-galactopyranose mutase in nematodes.Glycopolymer probes of signal transductionFidelity and Promiscuity of a Mycobacterial GlycosyltransferaseSynthesis of a multivalent display of a CD22-binding trisaccharide.ChemRXiv: A Chemistry Preprint Server.Comparing Galactan Biosynthesis in Mycobacterium tuberculosis and Corynebacterium diphtheriae.Recognition of microbial glycans by soluble human lectins.Carboxylate Surrogates Enhance the Antimycobacterial Activity of UDP-Galactopyranose Mutase Probes.The Ecstasy and Agony of Assay Interference Compounds.An asymmetric synthesis of L-pyrrolysine.The Ecstasy and Agony of Assay Interference Compounds.Flow cytometry reveals that multivalent chemoattractants effect swarmer cell dedifferentiation.Forces of Change: Mechanics Underlying Formation of Functional 3D Organ Buds.Synthesis of fluorogenic polymers for visualizing cellular internalization.ROMP from ROMP: A New Approach to Graft Copolymer SynthesisSelective immobilization of multivalent ligands for surface plasmon resonance and fluorescence microscopy.A strategy for the synthesis of sulfated peptides.Surface plasmon resonance imaging studies of protein-carbohydrate interactions.Conformational Control of UDP-Galactopyranose Mutase Inhibition.A symposium in honor of Peter B. Dervan, the 2014 ACS Chemical Biology Lectureship Award Winner.Taxation on Innovation.Nanoscience and Nanotechnology Cross Borders.Deleterious Consequences of UDP-Galactopyranose Mutase Inhibition for Nematodes.Correction to New Insights into Bacterial Chemoreceptor Array Structure and Assembly from Electron Cryotomography.Spotlight: A Conversation with Laura Kiessling and Jennifer Doudna.How many human proteoforms are there?Focus on Epigenetics.
P50
Q27657362-3A363E58-7364-4BC4-AEC3-211F1FC1E102Q28118757-972B90A0-A255-4A90-9EE7-BDB7F0CAB882Q33523341-EF60B952-C9E1-426F-9F41-775CB6559014Q33708971-F09B478E-D36F-4C33-BFB3-CD31D05321BDQ34108281-FDD7E30B-6019-4837-9083-D786DDA02882Q34319532-E6E8CF12-4777-4AA1-86D7-5F8B0696CEADQ34380952-85C492A6-435A-425C-97E8-0541C91F5555Q34508590-B71502A5-EED8-49B7-A458-AA0677F8270AQ35195319-42E4B13B-BD82-41E1-B26A-1D3DB404D483Q35231912-E9DBE6DA-44EA-4E23-A74C-E22CA439A982Q35983604-31A0763C-3661-499A-95FB-E49888A8E528Q36430287-1BCDC573-FD2C-4717-A183-D56A0774363DQ36897537-6A87372C-26CC-4819-85D7-BB3F4EB9EC5FQ37189388-6228EC74-1186-4275-B5C6-FD83B3D70CDDQ37257032-C06EFC0F-7B90-44B6-92E4-C3F39E09436FQ38292059-99FB67A2-DC58-499B-B8CE-A577D81231EFQ38361210-A1BC596A-92B0-4684-B664-E37A730723ABQ38376889-D461B32B-D974-4F07-A236-EF9F0EFAD4B9Q39048651-0D7D0C63-D745-4829-BB34-ACBBF94F21CCQ39291113-27F39EA6-6189-4C55-80D2-54FC2229C6B4Q39392401-60CCF3E6-D57A-42F0-AD57-E3B7B81A12E2Q40314472-65FA2410-13C2-4379-B278-B4ECF797A01EQ42003649-F460AFD6-8EA7-4FD9-8178-109836E56407Q42047280-C2567875-835F-4704-BAB1-AE7EB4428004Q42271397-3AE1610A-5CCC-428E-B98F-4EC327C40279Q42363158-EB8B96C7-E2FB-4946-B49F-3D01F4044034Q42605906-DF845FA4-F72C-4FCD-B7E0-8315178638C4Q42677958-F1A3109B-B1FC-4E26-AA34-B4185D6C514CQ44020630-0C64E906-D77F-4654-A02E-DDE04FE591D4Q44151916-C1B2C084-C771-477F-A0BE-D12B85AABC32Q44465239-74D7A444-A796-40FE-9A40-0607753C7E7FQ46351977-1B36DEFB-1956-4912-9685-D41155D00273Q48068455-6F323B3A-2840-4115-955C-05BF4D902146Q48115884-4981036B-26BB-46F0-A352-AF9D1E5ABD7AQ48234555-16BB56D8-AC6D-41E3-9633-96F482F4783EQ48365068-1E07729E-26D4-41C8-878E-705F15AC1438Q49191249-CFBDF14D-9DA8-4A44-A032-1E2DC7DFF940Q49964072-E3662214-662F-4CDA-BF62-D3E12BB01CBEQ50001631-35A4065C-B252-4C53-B936-0AD726288F07Q52425073-65411D3E-E5E8-4FCC-B5B2-231BD1C4AA16
P50
description
Ameerika Ühendriikide keemik
@et
American chemist
@en
Amerikaans scheikundige
@nl
US-amerikanische Biochemikerin
@de
Usana kemiisto
@io
amerikansk kemiker
@da
amerikansk kemist
@sv
amerikansk kjemikar
@nn
amerikansk kjemiker
@nb
ceimiceoir Meiriceánach
@ga
name
Laura L. Kiessling
@da
Laura L. Kiessling
@de
Laura L. Kiessling
@en-ca
Laura L. Kiessling
@en-gb
Laura L. Kiessling
@fr
Laura L. Kiessling
@hu
Laura L. Kiessling
@it
Laura L. Kiessling
@nb
Laura L. Kiessling
@nl
Laura L. Kiessling
@nn
type
label
Laura L. Kiessling
@da
Laura L. Kiessling
@de
Laura L. Kiessling
@en-ca
Laura L. Kiessling
@en-gb
Laura L. Kiessling
@fr
Laura L. Kiessling
@hu
Laura L. Kiessling
@it
Laura L. Kiessling
@nb
Laura L. Kiessling
@nl
Laura L. Kiessling
@nn
altLabel
Kiessling L
@en
Kiessling L. L.
@en
Kiessling L.
@en
Kiessling LL
@en
Kiessling
@en
L Kiessling
@en
L L Kiessling
@en
L. Kiessling
@en
L. L. Kiessling
@en
Laura Kiesling
@en
prefLabel
Laura L. Kiessling
@da
Laura L. Kiessling
@de
Laura L. Kiessling
@en-ca
Laura L. Kiessling
@en-gb
Laura L. Kiessling
@fr
Laura L. Kiessling
@hu
Laura L. Kiessling
@it
Laura L. Kiessling
@nb
Laura L. Kiessling
@nl
Laura L. Kiessling
@nn
P166
P214
P2163
P244
P269
P166
P19
P1960
VNyWLJ0AAAAJ
P21
P214
P2163
P2381
P244
n2001129002
P269
P31
P496
0000-0001-6829-1500